CURRENT AFFAIRS

2020

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

The COVID-19 vaccine developed by Gamalei Institute of Epidemiology and Microbiology has successfully completed the Human Clinical Trials. The institute belongs to which country?

A	USA
B	Russia
C	Germany
D	Poland

Explanation:

Detailed explanation-1: -The Gamaleya Research Institute of Epidemiology and Microbiology, previously the N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, is a Russian medical-research institute within the Ministry of Health of the Russian Federation.

Detailed explanation-2: -Gamaleya Research Center received an international patent for Ebola vaccine.

Detailed explanation-3: -COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

Detailed explanation-4: -Sputnik V - the first registered vaccine against COVID-19. Official website vaccine against coronavirus Sputnik V.

Detailed explanation-5: -Both COVOVAX™ (manufactured by Serum Institute of India Pvt Ltd) and Nuvaxovid (manufactured by Novavax) are SARS-CoV-2 rS Protein (COVID-19) Nanoparticle Vaccines.

There is 1 question to complete.